Sign in
4

Changes in Ownership

Cadrenal Therapeutics, Inc. Filed Acc 0001213900-25-103147

Chief Financial Officer sold 3,600 shares at $13.99 ($50,364)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Szot Matthew K · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-24 Sale : show line 1 in the form 10b5-1 −1,800 $13.99 $25,182 11,733 D
2025-10-27 Sale : show line 2 in the form 10b5-1 −1,800 $13.99 $25,182 9,933 D
Open-market sales · 3,600 sh · avg $13.99 · $50,364
Loading xslF345X05/ownership.xml…